Kbc Group Nv Biogen Inc. Transaction History

Kbc Group Nv

$33.1 Billion
Q2 2024

A detailed history of Kbc Group Nv transactions in Biogen Inc. stock. As of the latest transaction made, Kbc Group Nv holds 41,981 shares of BIIB stock, worth $7.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

41,981

Previous 45,507 7.75%

Holding current value

$7.3 Million

Previous $9.81 Million 0.83%

% of portfolio

0.03%

Previous 0.03%

43 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	SELL	$190.52 - $236.72 $671,773 - $834,674	-3,526 Reduced 7.75%	41,981 $9.73 Million
Q1 2024 May 08, 2024	SELL	$212.02 - $267.71 $1.13 Million - $1.43 Million	-5,329 Reduced 10.48%	45,507 $9.81 Million
Q4 2023 Feb 13, 2024	SELL	$222.59 - $267.94 $4.56 Million - $5.49 Million	-20,508 Reduced 28.75%	50,836 $13.2 Million
Q3 2023 Feb 15, 2024	SELL	$253.3 - $285.89 $6.04 Million - $6.81 Million	-23,832 Reduced 32.96%	48,478 $12.5 Million
Q2 2023 Feb 15, 2024	BUY	$275.25 - $318.06 $11.7 Million - $13.5 Million	42,508 Added 142.63%	72,310 $20.6 Million
Q2 2023 Jul 28, 2023	BUY	$275.25 - $318.06 $1.43 Million - $1.65 Million	5,188 Added 7.84%	71,344 $20.3 Million
Q1 2023 Feb 14, 2024	BUY	$256.56 - $292.34 $7.41 Million - $8.44 Million	28,878 Added 74.93%	67,419 $18.7 Million
Q1 2023 May 04, 2023	BUY	$256.56 - $292.34 $9.6 Million - $10.9 Million	37,427 Added 130.28%	66,156 $18.4 Million
Q4 2022 Feb 14, 2024	BUY	$252.44 - $306.72 $1.6 Million - $1.95 Million	6,345 Added 19.71%	38,541 $10.7 Million
Q3 2022 Feb 15, 2024	SELL	$194.69 - $268.46 $4.1 Million - $5.65 Million	-21,034 Reduced 41.38%	29,802 $7.96 Million
Q3 2022 Nov 08, 2022	SELL	$194.69 - $268.46 $470,371 - $648,599	-2,416 Reduced 7.76%	28,729 $7.67 Million
Q2 2022 Feb 14, 2024	SELL	$187.54 - $223.02 $268,744 - $319,587	-1,433 Reduced 4.26%	32,196 $6.57 Million
Q2 2022 Jul 26, 2022	SELL	$187.54 - $223.02 $465,849 - $553,981	-2,484 Reduced 7.39%	31,145 $6.35 Million
Q1 2022 Feb 14, 2024	SELL	$193.77 - $244.14 $1.37 Million - $1.73 Million	-7,067 Reduced 17.37%	33,629 $7.08 Million
Q1 2022 May 06, 2022	SELL	$193.77 - $244.14 $1.37 Million - $1.73 Million	-7,067 Reduced 17.37%	33,629 $7.08 Million
Q4 2021 Feb 14, 2024	SELL	$223.92 - $287.77 $2.27 Million - $2.92 Million	-10,140 Reduced 19.95%	40,696 $9.76 Million
Q4 2021 Feb 03, 2022	SELL	$223.92 - $287.77 $1.3 Million - $1.67 Million	-5,801 Reduced 12.48%	40,696 $9.76 Million
Q3 2021 Nov 10, 2021	SELL	$282.99 - $369.05 $320,627 - $418,133	-1,133 Reduced 2.38%	46,497 $13.2 Million
Q2 2021 Aug 11, 2021	BUY	$259.0 - $414.71 $125,097 - $200,304	483 Added 1.02%	47,630 $16.5 Million
Q1 2021 Apr 26, 2021	SELL	$242.95 - $284.63 $471,080 - $551,897	-1,939 Reduced 3.95%	47,147 $13.2 Million
Q4 2020 Feb 10, 2021	SELL	$236.26 - $355.63 $10 Million - $15.1 Million	-42,433 Reduced 46.37%	49,086 $12 Million
Q3 2020 Oct 28, 2020	BUY	$264.77 - $305.71 $607,647 - $701,604	2,295 Added 2.57%	91,519 $26 Million
Q2 2020 Aug 10, 2020	SELL	$258.66 - $342.55 $11.4 Million - $15 Million	-43,920 Reduced 32.99%	89,224 $23.9 Million
Q1 2020 May 04, 2020	SELL	$268.85 - $341.04 $2.82 Million - $3.57 Million	-10,479 Reduced 7.3%	133,144 $42.1 Million
Q4 2019 Feb 11, 2020	SELL	$220.06 - $304.07 $2.56 Million - $3.53 Million	-11,623 Reduced 7.49%	143,623 $42.6 Million
Q3 2019 Nov 07, 2019	BUY	$217.44 - $243.88 $33.6 Million - $37.7 Million	154,740 Added 30581.03%	155,246 $36.1 Million
Q2 2019 Dec 03, 2019	SELL	$219.29 - $241.72 $18.2 Million - $20 Million	-82,841 Reduced 99.39%	506 $118,000
Q2 2019 Jul 30, 2019	BUY	$219.29 - $241.72 $18.2 Million - $20 Million	82,841 Added 16371.74%	83,347 $0
Q1 2019 Dec 03, 2019	SELL	$216.71 - $338.96 $17.4 Million - $27.3 Million	-80,447 Reduced 99.37%	506 $120,000
Q1 2019 May 10, 2019	BUY	$216.71 - $338.96 $17.4 Million - $27.3 Million	80,447 Added 15898.62%	80,953 $0
Q4 2018 Dec 03, 2019	SELL	$278.5 - $352.75 $13.5 Million - $17 Million	-48,298 Reduced 98.96%	506 $152,000
Q4 2018 Jan 31, 2019	BUY	$278.5 - $352.75 $13.4 Million - $17 Million	48,068 Added 6530.98%	48,804 $14.7 Million
Q3 2018 Dec 03, 2019	SELL	$293.51 - $383.83 $19.8 Million - $25.9 Million	-67,423 Reduced 98.92%	736 $260,000
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $19.8 Million - $25.9 Million	67,423 Added 9160.73%	68,159 $0
Q2 2018 Dec 03, 2019	SELL	$257.52 - $306.91 $20.6 Million - $24.5 Million	-79,886 Reduced 99.09%	736 $214,000
Q2 2018 Aug 03, 2018	BUY	$257.52 - $306.91 $20.6 Million - $24.5 Million	79,886 Added 10854.08%	80,622 $0
Q1 2018 Dec 03, 2019	SELL	$260.13 - $367.91 $30.6 Million - $43.3 Million	-117,786 Reduced 99.38%	736 $202,000
Q1 2018 May 09, 2018	BUY	$260.13 - $367.91 $30.6 Million - $43.3 Million	117,786 Added 16003.53%	118,522 $0
Q4 2017 Dec 03, 2019	SELL	$307.64 - $344.58 $37.4 Million - $41.9 Million	-121,679 Reduced 99.4%	736 $234,000
Q4 2017 Feb 07, 2018	BUY	$307.64 - $344.58 $37.4 Million - $41.9 Million	121,679 Added 16532.47%	122,415 $0
Q3 2017 Dec 03, 2019	SELL	$281.15 - $329.69 $22.2 Million - $26 Million	-78,976 Reduced 99.08%	736 $230,000
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $22.2 Million - $26 Million	78,976 Added 10730.43%	79,712 $0
Q2 2017 Dec 03, 2019	BUY	N/A	736	736 $200,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account